Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Harrow, Inc.(HROW) | 3,920,600 | 3,990,000 | +69,400 | $51.87M | $83.35M | 19.04% | +$31.48M |
| TG Therapeutics, Inc.(TGTX) | 2,280,000 | 2,280,000 | 0 | $34.68M | $40.56M | 9.27% | +$5.88M |
| Ocular Therapeutix, Inc.(OCUL) | 6,653,138 | 5,307,500 | -1,345,638 | $60.54M | $36.30M | 8.29% | -$24.24M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 515,000 | 515,000 | 0 | $22.31M | $21.15M | 4.83% | -$1.17M |
| Keros Therapeutics, Inc.(KROS) | 367,500 | 367,500 | 0 | $24.33M | $16.79M | 3.84% | -$7.53M |
| Arvinas, Inc.(ARVN) | 330,000 | 555,000 | +225,000 | $13.62M | $14.77M | 3.38% | +$1.15M |
| Immunome, Inc.(IMNM) | 0 | 1,102,500 | +1,102,500 | $0 | $13.34M | 3.05% | +$13.34M |
| Cytokinetics, Incorporated(CYTK) | 0 | 198,500 | +198,500 | $0 | $10.75M | 2.46% | +$10.75M |
| Codexis, Inc.(CDXS) | 3,120,000 | 3,455,000 | +335,000 | $10.89M | $10.71M | 2.45% | -$178.3K |
| Edgewise Therapeutics, Inc.(EWTX) | 665,000 | 580,000 | -85,000 | $12.13M | $10.45M | 2.39% | -$1.68M |
| Catalyst Pharmaceuticals Inc | 1,004,355 | 640,000 | -364,355 | $16.01M | $9.91M | 2.27% | -$6.10M |
| Cargo Therapeutics Inc | 0 | 555,700 | +555,700 | $0 | $9.12M | 2.08% | +$9.12M |
| Jasper Therapeutics, Inc.(JSPR) | 435,573 | 392,000 | -43,573 | $12.79M | $8.90M | 2.03% | -$3.89M |
| Nurix Therapeutics, Inc.(NRIX) | 267,210 | 418,928 | +151,718 | $3.93M | $8.74M | 2.00% | +$4.82M |
| Trevi Therapeutics, Inc.(TRVI) | 2,645,000 | 2,645,000 | 0 | $9.13M | $7.88M | 1.80% | -$1.24M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,445,781 | 2,395,000 | -50,781 | $9.17M | $7.88M | 1.80% | -$1.29M |
| Applied Therapeutics Inc' | 1,770,000 | 1,680,000 | -90,000 | $12.04M | $7.85M | 1.79% | -$4.19M |
| 4d Molecular Therapeutics Inc | 344,123 | 345,750 | +1,627 | $10.96M | $7.26M | 1.66% | -$3.71M |
| Iovance Biotherapeutics, Inc.(IOVA) | 897,000 | 897,000 | 0 | $13.29M | $7.19M | 1.64% | -$6.10M |
| Acelyrin Inc | 1,580,000 | 1,580,000 | 0 | $10.66M | $6.97M | 1.59% | -$3.70M |
| UroGen Pharma Ltd.(URGN) | 270,000 | 412,000 | +142,000 | $4.05M | $6.91M | 1.58% | +$2.86M |
| Vaxcyte, Inc.(PCVX) | 85,000 | 85,000 | 0 | $5.81M | $6.42M | 1.47% | +$612.0K |
| Biodesix, Inc.(BDSX) | 534,657 | 4,020,000 | +3,485,343 | $764.6K | $6.15M | 1.41% | +$5.39M |
| Newamsterdam Pharma Company ORDINARY SHARES | 315,388 | 315,000 | -388 | $7.46M | $6.05M | 1.38% | -$1.41M |
| Xoma Corp Del | 250,000 | 250,000 | 0 | $6.01M | $5.92M | 1.35% | -$90.0K |
| Protara Therapeutics, Inc.(TARA) | 2,692,594 | 2,304,262 | -388,332 | $10.80M | $5.30M | 1.21% | -$5.50M |
| Intellia Therapeutics, Inc.(NTLA) | 255,000 | 218,000 | -37,000 | $7.02M | $4.88M | 1.11% | -$2.14M |
| Nuvalent Inc | 0 | 59,300 | +59,300 | $0 | $4.50M | 1.03% | +$4.50M |
| Syros Pharmaceuticals Inc | 787,545 | 865,443 | +77,898 | $4.21M | $4.47M | 1.02% | +$252.9K |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 0 | 0 | 0 | $3.21M | $3.96M | 0.90% | +$744.8K |
| Liquidia Corporation(LQDA) | 395,000 | 325,000 | -70,000 | $5.83M | $3.90M | 0.89% | -$1.93M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $0 | $3.75M | 0.86% | +$3.75M |
| Protagonist Therapeutics Inc | 112,700 | 105,000 | -7,700 | $3.26M | $3.64M | 0.83% | +$377.8K |
| Gossamer Bio, Inc.(GOSS) | 2,440,109 | 3,910,000 | +1,469,891 | $2.88M | $3.52M | 0.80% | +$643.2K |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 0 | 1,875,000 | +1,875,000 | $0 | $3.15M | 0.72% | +$3.15M |
| Savara Inc.(SVRA) | 855,000 | 714,960 | -140,040 | $4.26M | $2.88M | 0.66% | -$1.38M |
| Allakos Inc | 2,435,000 | 2,780,000 | +345,000 | $3.07M | $2.78M | 0.64% | -$288.1K |
| Ventyx Biosciences Inc | 1,285,000 | 1,190,000 | -95,000 | $7.07M | $2.75M | 0.63% | -$4.32M |
| Verastem, Inc.(VSTM) | 211,400 | 915,000 | +703,600 | $2.49M | $2.73M | 0.62% | +$232.2K |
| Regulus Therapeutics Inc | 170,308 | 1,475,000 | +1,304,692 | $490.5K | $2.63M | 0.60% | +$2.14M |
| Lyell Immunopharma, Inc.(LYEL) | 3,355,000 | 1,670,000 | -1,685,000 | $7.48M | $2.42M | 0.55% | -$5.06M |
| Relmada Therapeutics, Inc.(RLMD) | 759,000 | 600,000 | -159,000 | $3.53M | $1.80M | 0.41% | -$1.73M |
| Fulcrum Therapeutics, Inc.(FULC) | 130,000 | 285,000 | +155,000 | $1.23M | $1.77M | 0.40% | +$539.8K |
| Karyopharm Therapeutics Inc.(KPTI) | 0 | 1,425,000 | +1,425,000 | $0 | $1.24M | 0.28% | +$1.24M |
| iBio, Inc.(IBIO) | 680,000 | 375,000 | -305,000 | $2.76M | $791.3K | 0.18% | -$1.97M |
| PMV Pharmaceuticals, Inc.(PMVP) | 471,481 | 475,000 | +3,519 | $802.1K | $769.5K | 0.18% | -$32.6K |
| Aerovate Therapeutics Inc | 0 | 440,000 | +440,000 | $0 | $730.4K | 0.17% | +$730.4K |
| Design Therapeutics, Inc.(DSGN) | 113,038 | 205,000 | +91,962 | $455.5K | $686.8K | 0.16% | +$231.2K |
| AbCellera Biologics Inc.(ABCL) | 0 | 200,000 | +200,000 | $0 | $592.0K | 0.14% | +$592.0K |
| Aligos Therapeutics Inc | 1,630,000 | 1,260,000 | -370,000 | $1.60M | $441.0K | 0.10% | -$1.16M |
| Reneo Pharmaceuticals Inc | 0 | 165,000 | +165,000 | $0 | $249.2K | 0.06% | +$249.2K |
| Compass Therapeutics, Inc.(CMPX) | 3,170,000 | 0 | -3,170,000 | $6.28M | $0 | — | -$6.28M |
| Context Therapeutics Inc.(CNTX) | 1,108,357 | 0 | -1,108,357 | $1.53M | $0 | — | -$1.53M |
| Crinetics Pharmaceuticals Inc | 210,000 | 0 | -210,000 | $9.83M | $0 | — | -$9.83M |
| Glaukos Corporation(GKOS) | 8,576 | 0 | -8,576 | $808.6K | $0 | — | -$808.6K |
| Larimar Therapeutics, Inc.(LRMR) | 174,413 | 0 | -174,413 | $1.32M | $0 | — | -$1.32M |
| Morphosys AgADS | 65,000 | 0 | -65,000 | $1.18M | $0 | — | -$1.18M |
| Nyxoah S ASHS SHS | 320,000 | 0 | -320,000 | $4.32M | $0 | — | -$4.32M |
| Precigen, Inc.(PGEN) | 947,500 | 0 | -947,500 | $1.37M | $0 | — | -$1.37M |
| REPARE THERAPEUTICS iNC | 67,561 | 0 | -67,561 | $318.2K | $0 | — | -$318.2K |
| Revance Therapeutics Inc | 785,000 | 0 | -785,000 | $3.86M | $0 | — | -$3.86M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 200,000 | 0 | -200,000 | $3.15M | $0 | — | -$3.15M |